⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL604339 | 0.96 | — | — | |
| SCHEMBL169425 | 0.96 | — | — | |
| SCHEMBL21467045 | 0.96 | CHRM5 (0.39) | — | |
| SCHEMBL602116 | 0.92 | — | — | |
| SCHEMBL2686980 | 0.85 | CHRM5 (0.33) | — | |
| SCHEMBL322743 | 0.84 | — | — | |
| SCHEMBL13817489 | 0.83 | SIGMAR1 (0.34) | — | |
| SCHEMBL14616112 | 0.81 | SIGMAR1 (0.33) | — | |
| SCHEMBL18691426 | 0.81 | EPHX1 (0.32) | — | |
| SCHEMBL14472942 | 0.78 | ALDH1A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019156541-A1 | COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT | 주식회사 지앤피바이오사이언스 | 2019-08-15 | — | — | WO | claimed |
| US-20180008523-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | DEVICEFARM INC (US) | 2018-01-11 | — | — | US | claimed |
| US-20180000937-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | DEVICEFARM INC (US) | 2018-01-04 | — | — | US | claimed |
| US-20170361078-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-21 | — | — | US | claimed |
| US-20170354616-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-14 | — | — | US | claimed |
| US-20170354815-A1 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | NATIONAL SCIENCE FOUNDATION | 2017-12-14 | — | — | US | claimed |
| EP-2044192-A2 | ENHANCED OXYGEN CELL CULTURE PLATFORMS | University of Miami (US) | 2009-04-08 | — | — | EP | claimed |
| WO-2008006104-A2 | ENHANCED OXYGEN CELL CULTURE PLATFORMS | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080009027-A1 | Enhanced Oxygen Cell Culture Platforms | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | US | claimed |
| US-7081092-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL COMPANY (US) | 2006-07-25 | — | — | US | claimed |
| US-20050049484-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2005-03-03 | — | — | US | claimed |
| US-6802813-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL CO. | 2004-10-12 | — | — | US | claimed |
| US-20030220563-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2003-11-27 | — | — | US | claimed |
| US-20020065467-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | SCHUTT ERNEST G (US) | 2002-05-30 | — | — | US | claimed |
| WO-1998053855-A1 | METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-03 | — | — | WO | claimed |
| WO-1995004046-A1 | COMPOUNDS AS PDE IV AND TNF INHIBITORS | RHONE-POULENC RORER LIMITED (GB) | 1995-02-09 | — | — | WO | claimed |
| US-20250009652-A1 | COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS | PEARL THERAPEUTICS, INC. | 2025-01-09 | — | — | US | disclosed |
| EP-4398368-A1 | ELECTROLYTE SOLUTION, BATTERY CELL COMPRISING SAME, BATTERY AND ELECTRIC DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2024-07-10 | — | — | EP | disclosed |
| WO-1995004046-A1 | COMPOUNDS AS PDE IV AND TNF INHIBITORS | RHONE-POULENC RORER LIMITED (GB) | 1995-02-09 | — | — | WO | disclosed |
| WO-1993017651-A2 | ANTIVIRAL NUCLEOSIDE ANALOGUES, THEIR PRODUCTION AND USE | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 1993-09-16 | — | — | WO | disclosed |